Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.81 USD
Change Today +0.035 / 0.93%
Volume 35.7K
OCRX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:27 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph M. Davie M.D., Ph.D.

Former Director, Ocera Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 4 different organizations across 11 different industries.

See Board Relationships
74--

Background*

Dr. Joseph M. Davie served as a Vice President and Senior Vice President of Research at Bigen Inc., from 1993 to 2000. From 1987 to 1993, he held several positions at G.D. Searle & Co. including a Senior Vice President of Research from 1987 to 1989, President of Research and Development from 1987 to 1992, and Corporate Senior Vice President of Science an Technology in 1993. Dr. Davie served as a Director of Ocera Therapeutics, Inc. since March 1, 2006. Dr. Davie serves ...

Read Full Background

Corporate Headquarters*

525 University Avenue
Palo Alto, California 94301

United States

Phone: 650-475-0158
Fax: 650-521-5677

Board Members Memberships*

Former Director
Former Director
Former Director
Director
2000-2010
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2000-2009
Former Director and Member of Compensation Committee
2001-N/A
Former Director
2003-2011
Former Director and Member of Scientific Advisory Board
2003-2007
Former Independent Director and Chairman of Human Resources & Compensation Committee
2003-N/A
Former Director
2006-N/A
Former Director and Member of Compensation Committee
2006-N/A
Former Director

Education*

Post-Doctoral Training
Washington University, St. Louis
MD 1968
Washington University, St. Louis
MA
Indiana University, Bloomington
PhD 1966
Indiana University, Bloomington
BA
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCRX:US $3.81 USD +0.035

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Ricardo J. Gonzalez Chief Executive Officer, President and Director
Navidea Biopharmaceuticals, Inc
$82.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCERA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.